DataString Consulting Company Logo
DataString Consulting Company Logo
Neurostimulation Devices Market
Home»Top Market Reports»Neurostimulation Devices Market

Neurostimulation Devices Market

Author: Debadatta Patel - Senior Consultant, Report ID - DS1801006, Published - November 2024

Segmented in Type (Spinal Cord Stimulators, Deep Brain Stimulators, Sacral Nerve Stimulators, Vagus Nerve Stimulators), Application (Pain Management, Parkinson's Disease, Epilepsy, Depression), End User and Regions - Global Industry Analysis, Size, Share, Trends, and Forecast 2023 – 2033

Share this report:

Neurostimulation Devices Market Outlook

Neurostimulation devices, designed to deliver electrical impulses to specific nerve targets, play a critical role in managing chronic pain and neurological conditions such as Parkinson's disease, epilepsy, and depression. In 2023, the neurostimulation device market was valued at approximately USD 7.6 billion, with projections to reach USD 16.5 billion by 2030 and potentially USD 28.7 billion by 2035, growing at a CAGR of 11.7%. This growth is attributed to increasing incidences of neurological disorders and advancements in non-invasive neurostimulation technologies.


Neurostimulation devices have proven effective in enhancing patients’ quality of life by alleviating chronic pain and managing symptoms of debilitating conditions. With rising healthcare awareness and ongoing innovations, these devices are becoming integral to neurological and pain management therapies


Market Size Forecast & Key Insights

2018
$7.6B2023
2028
$23B2033

Absolute Growth Opportunity = $15.4B

The Neurostimulation Devices market is projected to grow from $7.6 billion in 2023 to $23.0 billion in 2033. This represents a CAGR of 11.7%, reflecting rising demand across Pain Management, Epilepsy and Parkinson's Disease.

The Neurostimulation Devices market is set to add $15.4 billion between 2023 and 2033, with manufacturer targeting Parkinson's Disease & Epilepsy Application projected to gain a larger market share.

With Increasing prevalence of neurological disorders, and Growth in chronic pain management applications, Neurostimulation Devices market to expand 202% between 2023 and 2033.

Opportunities in the Neurostimulation Devices Market

Expansion into Emerging Markets

Emerging healthcare markets present significant growth opportunities for neurostimulation device adoption, particularly in pain management

Development of Miniaturized and Wearable Devices and Increased Applications in Mental Health Disorders

Advances in miniaturization and wearable neurostimulation devices enable broader usage in home care and outpatient settings

As research into neurostimulation’s impact on mental health advances, new applications in treating depression and anxiety present a growth area

Growth Opportunities in North America and Europe

Europe Outlook

Europe, particularly Germany and the United Kingdom, shows growing adoption of neurostimulation devices in chronic pain and neurological care. Companies such as Abbott and Nevro Corp lead in this market

North America Outlook

North America leads in neurostimulation device demand, supported by a high incidence of neurological disorders and advanced healthcare infrastructure. Key players like Medtronic and Boston Scientific are prominent in this region

North America Outlook

North America leads in neurostimulation device demand, supported by a high incidence of neurological disorders and advanced healthcare infrastructure. Key players like Medtronic and Boston Scientific are prominent in this region

Europe Outlook

Europe, particularly Germany and the United Kingdom, shows growing adoption of neurostimulation devices in chronic pain and neurological care. Companies such as Abbott and Nevro Corp lead in this market

Growth Opportunities in North America and Europe

Established and Emerging Market's Growth Trend 2024–2033

1

Major Markets : United States, Germany, Japan, China, United Kingdom are expected to grow at 8.5% to 12.3% CAGR

2

Emerging Markets : India, Brazil, South Korea are expected to grow at 11.2% to 14.6% CAGR

Market Analysis Chart

The neurostimulation device market is driven by demand for chronic pain management and neurological disorder treatments, though high costs and regulatory hurdles remain challenges. Opportunities exist in emerging markets, wearable devices, and mental health applications

Recent Developments and Technological Advancement

October 2024

Boston Scientific launched a wearable neurostimulation device for chronic pain, targeting outpatient care

July 2024

Medtronic expanded its deep brain stimulation offerings with an enhanced system for Parkinson’s treatment

March 2024

LivaNova introduced a new vagus nerve stimulator designed to improve seizure control in epilepsy patients

Recent advancements in neurostimulation devices focus on wearable and miniaturized solutions. Boston Scientific’s wearable device supports pain management in outpatient care, Medtronic expands Parkinson’s solutions, and LivaNova enhances seizure control in epilepsy

Impact of Industry Transitions on the Neurostimulation Devices Market

As a core segment of the Medical Device industry, the Neurostimulation Devices market develops in line with broader industry shifts. Over recent years, transitions such as Shift Toward Wearable Neurostimulation Solutions and Advancements in Device Miniaturization have redefined priorities across the Medical Device sector, influencing how the Neurostimulation Devices market evolves in terms of demand, applications and competitive dynamics. These transitions highlight the structural changes shaping long-term growth opportunities.

1

Shift Toward Wearable Neurostimulation Solutions:

Wearable devices make neurostimulation therapy more accessible and convenient, especially for patients in outpatient care

2

Advancements in Device Miniaturization:

New miniaturized devices improve patient comfort and expand the applications of neurostimulation in various therapeutic areas

Global Events Shaping Future Growth

The chart below highlights how external events including emerging market developments, regulatory changes, and technological disruptions, have added another layer of complexity to the Medical Device industry. These events have disrupted supply networks, changed consumption behavior, and reshaped growth patterns. Together with structural industry transitions, they demonstrate how changes within the Medical Device industry cascade into the Neurostimulation Devices market, setting the stage for its future growth trajectory.

Market Dynamics and Supply Chain

Driver: Increasing Prevalence of Neurological Disorders, and Technological Advancements in Non-Invasive Neurostimulation

Rising cases of conditions like Parkinsons and epilepsy drive demand for neurostimulation devices in managing symptoms
Developments in non-invasive devices enhance patient comfort and expand applications, boosting the adoption of neurostimulation therapy
With chronic pain affecting millions globally, neurostimulation devices provide an effective solution, especially in cases where traditional treatments are also inadequate

Restraint: High Costs of Neurostimulation Devices, and Risk of Device Malfunction or Infection

The high cost of devices and surgical implantation limits accessibility, particularly in low-income regions
As with any implantable device, there are risks of malfunction or infection, which can limit patient adoption and trust in neurostimulation therapy

Challenge: Complex Regulatory Approvals

Stringent regulations and lengthy approval processes impact the availability of neurostimulation devices

Supply Chain Landscape

Raw Material Supplier

3M

DuPont

Device Manufacturer / Assembler

Medtronic

Boston Scientific

Distributor
McKesson / Cardinal Health
End-User
Hospitals / Clinics / Home Care
Raw Material Supplier

3M

DuPont

Device Manufacturer / Assembler

Medtronic

Boston Scientific

Distributor

McKesson

Cardinal Health

End-User

Hospitals

Clinics

Home Care

Banner LogoBanner Logo

Leading Providers and Their Strategies

Application AreaIndustryLeading ProvidersProvider Strategies
Pain Management
Healthcare
Boston Scientific
Developing wearable devices for chronic pain in outpatient settings
Parkinson's Disease
Neurology
Medtronic
Enhancing deep brain stimulation systems for symptom control
Epilepsy
Neurotherapy
LivaNova
Offering advanced vagus nerve stimulators for seizure reduction
Depression
Mental Health
NeuroStar
Providing TMS devices for treatment-resistant depression

Elevate your strategic vision with in-depth analysis of key applications, leading market players, and their strategies. The report analyzes industry leaders' views and statements on the Neurostimulation Devices market's present and future growth.

Our research is created following strict editorial standards. See our Editorial Policy

Applications of Neurostimulation Devices in Epilepsy, Parkinson's Disease and Pain Management

Epilepsy

Vagus nerve stimulators reduce seizure frequency in epilepsy patients, offering a non-invasive alternative to manage epilepsy. Key providers include LivaNova and Cyberonics

Parkinson's Disease

Deep brain stimulators help control symptoms of Parkinson's disease, such as tremors, by targeting specific brain areas. Companies like Medtronic and Abbott specialize in this segment

Pain Management

Neurostimulation devices, particularly spinal cord stimulators, are extensively used for chronic pain relief, improving patient outcomes in conditions such as back pain and sciatica. Leading providers include Boston Scientific and Nevro Corp

Neurostimulation Devices vs. Substitutes:
Performance and Positioning Analysis

While alternatives like pharmacological treatments and physical therapy exist, neurostimulation devices offer unique benefits in chronic and neurological conditions. Despite alternatives, the neurostimulation device market is expected to grow due to increasing demand for effective and non-invasive therapies

Neurostimulation Devices
  • Pharmacological Painkillers /
  • Physical Therapy /
  • Cognitive Behavioral Therapy
    Effective in Reducing Pain and Managing Neurological Symptoms
    High Cost and Invasive Nature for Some Devices
    Low Cost and Accessible
    Limited Efficacy for Chronic and Severe Conditions

Neurostimulation Devices vs. Substitutes:
Performance and Positioning Analysis

Neurostimulation Devices

  • Effective in Reducing Pain and Managing Neurological Symptoms
  • High Cost and Invasive Nature for Some Devices

Pharmacological Painkillers / Physical Therapy / Cognitive Behavioral Therapy

  • Low Cost and Accessible
  • Limited Efficacy for Chronic and Severe Conditions

While alternatives like pharmacological treatments and physical therapy exist, neurostimulation devices offer unique benefits in chronic and neurological conditions. Despite alternatives, the neurostimulation device market is expected to grow due to increasing demand for effective and non-invasive therapies

Loading...

Research Methodology

This market research methodology defines the Neurostimulation Devices market scope, gathers reliable data, and validates findings using integrated primary and secondary research. Our systematic framework ensures precise market sizing, growth trend analysis, and competitive benchmarking.


Secondary Research Approach


We begin secondary research by defining the targeted market at Country and Regional levels. As part of the Medical Device ecosystem, we analyze Neurostimulation Devices across Hospitals, Ambulatory Surgery Centers, and Home Care Settings Applications. Our team gathers data systematically from country level ministerial sources, industry associations & federations, trade databases, company annual & quarterly reports and other credential sources, enabling us to map global and regional market size, pricing trends, regulatory standards, and technology advancements.


Key Sources Referenced:


We benchmark competitors such as Medtronic, Boston Scientific, and Nevro Corp by reviewing company financial statements, and regulatory filings. Our secondary insights identify key market drivers and constraints, forming the analytical foundation for primary research.


Primary Research Methods


We conduct structured interviews and surveys with industry stakeholders, including Raw Material Supplier, Device Manufacturer / Assembler, and Distributor. Our geographic coverage spans Americas (40%), Europe (30%), Asia-Pacific (25%) and Middle East & Africa (5%). Our online surveys generally achieve a response rate of above 65%, and telephone interviews yield 60%, resulting in above 92% confidence level with a ±7% margin of error.


Through targeted questionnaires and in-depth interviews, we capture purchase intent, adoption barriers, brand perception across Segment Type. We use interview guides to ensure consistency and anonymous survey options to mitigate response bias. These primary insights validate secondary findings and align market sizing with real-world conditions.


Market Engineering & Data Analysis Framework


Our data analysis framework integrates Top-Down, Bottom-Up, and Company Market Share approaches to estimate and project market size with precision.


Top-down & Bottom-Up Process


In Top-down approach, we disaggregate global Medical Device revenues to estimate the Neurostimulation Devices segment, using historical growth patterns to set baseline trends. Simultaneously, in Bottom-up approach, we aggregate Country-Level Demand Data to derive regional and global forecasts, which provide granular consumption insights. By reconciling both approaches, we ensure statistical precision and cross-validation accuracy.


We evaluate the supply chain, spanning Raw Material Supplier (3M, DuPont), Device Manufacturer / Assembler (Medtronic, Boston Scientific), and Distributor. Our parallel substitute analysis examines Pharmacological Painkillers, Physical Therapy, and Cognitive Behavioral Therapy, highlighting diversification opportunities and competitive risks.


Company Market Share & Benchmarking


We benchmark leading companies such as Medtronic, Boston Scientific, and Nevro Corp, analyzing their capabilities in pricing, product features, technology adoption, and distribution reach. By assessing company-level revenues and product portfolios, we derive market share comparisons, clarifying competitive positioning and growth trajectories across the ecosystem.


Our integration of data triangulation, supply chain evaluation, and company benchmarking, supported by our proprietary Directional Superposition methodology enables us to deliver precise forecasts and actionable strategic insights into the Neurostimulation Devices market.


Quality Assurance and Compliance


We cross-reference secondary data with primary inputs and external expert reviews to confirm consistency. Further, we use stratified sampling, anonymous surveys, third-party interviews, and time-based sampling to reduce bias and strengthen our results.


Our methodology is developed in alignment with ISO 20252 standards and ICC/ESOMAR guidelines for research ethics. The study methodology follows globally recognized frameworks such as ISO 20252 and ICC codes of practice.

rm

Neurostimulation Devices Market Data: Size, Segmentation & Growth Forecast

Report AttributeDetails
Market Value in 2024USD 8.5 billion
Revenue Forecast in 2033USD 23.0 billion
Growth RateCAGR of 11.7% from 2024 to 2033
Base Year for Estimation2023
Industry Revenue 20237.6 billion
Growth OpportunityUSD 15.4 billion
Historical Data2018 - 2022
Growth Projection / Forecast Period2024 - 2033
Market Size UnitsMarket Revenue in USD billion and Industry Statistics
Market Size 20237.6 billion USD
Market Size 202610.6 billion USD
Market Size 202813.2 billion USD
Market Size 203016.5 billion USD
Market Size 203323.0 billion USD
Market Size 203528.7 billion USD
Report CoverageMarket revenue for past 5 years and forecast for future 10 years, Competitive Analysis & Company Market Share, Strategic Insights & trends
Segments CoveredType, Application, End User
Regional scopeNorth America, Europe, Asia Pacific, Latin America and Middle East & Africa
Country scopeU.S., Canada, Mexico, UK, Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Mexico, Argentina, Saudi Arabia, UAE and South Africa
Companies ProfiledMedtronic, Boston Scientific, Nevro Corp, Abbott, LivaNova, Cyberonics, NeuroStar, BrainsWay, Natus Medical, Stimwave, Greatbatch Medical and Aleva Neurotherapeutics
CustomizationFree customization at segment, region or country scope and direct contact with report analyst team for 10 to 20 working hours for any additional niche requirement which is almost equivalent to 10% of report value

Explore Report Features and Data Packages

Industry Insight Report

$ 4200
Unlock Multi-User Access for just $999 more
i
No Payment Before Report Delivery
Flexible Payment Options
Additional Features
Customization Available
i
Excel Data Pack Included
Free Analyst Support
i
Industry Expert-Validated Insights
100% Confidentiality Guaranteed
Fast Delivery (24–72 hours)
i
Get Report Now

Strategic Growth Advisory

Unrivaled Custom Market Intelligence & Strategic Advisory for Business Growth and Competitive Excellence

  • Assess and prioritize high-value markets with precision
  • Craft tailored entry and expansion roadmaps
  • De-risk investments through rigorous market intelligence
  • Architect dynamic pricing frameworks aligned to value creation
  • Unlock sustainable margin enhancement opportunities
  • Benchmark performance against global industry leaders
  • Strategically realign portfolios to future growth drivers
  • Accelerate commercialization of breakthrough offerings
  • Harness market foresight and technology shifts to fuel innovation

Discover our Strategic Growth Advisory Services »

Table of Contents

Industry Insights Report - Table Of Contents

Chapter 1

Executive Summary

Major Markets & Their Performance - Statistical Snapshots

Chapter 2

Research Methodology

2.1Axioms & Postulates
2.2Market Introduction & Research MethodologyEstimation & Forecast Parameters / Major Databases & Sources
Chapter 3

Market Dynamics

3.1Market OverviewDrivers / Restraints / Opportunities / M4 Factors
3.2Market Trends
3.2.1Introduction & Narratives
3.2.2Market Trends - Impact Analysis(Short, Medium & Long Term Impacts)
3.3Supply Chain Analysis
3.4Porter's Five ForcesSuppliers & Buyers' Bargaining Power, Threat of Substitution & New Market Entrants, Competitive Rivalry
Chapter 4

Neurostimulation Devices Market Size, Opportunities & Strategic Insights, by Type

4.1Spinal Cord Stimulators
4.2Deep Brain Stimulators
4.3Sacral Nerve Stimulators
4.4Vagus Nerve Stimulators
Chapter 5

Neurostimulation Devices Market Size, Opportunities & Strategic Insights, by Application

5.1Pain Management
5.2Parkinson's Disease
5.3Epilepsy
5.4Depression
Chapter 6

Neurostimulation Devices Market Size, Opportunities & Strategic Insights, by End User

6.1Hospitals
6.2Ambulatory Surgery Centers
6.3Home Care Settings
Chapter 7

Neurostimulation Devices Market, by Region

7.1North America Neurostimulation Devices Market Size, Opportunities, Key Trends & Strategic Insights
7.1.1U.S.
7.1.2Canada
7.2Europe Neurostimulation Devices Market Size, Opportunities, Key Trends & Strategic Insights
7.2.1Germany
7.2.2France
7.2.3UK
7.2.4Italy
7.2.5The Netherlands
7.2.6Rest of EU
7.3Asia Pacific Neurostimulation Devices Market Size, Opportunities, Key Trends & Strategic Insights
7.3.1China
7.3.2Japan
7.3.3South Korea
7.3.4India
7.3.5Australia
7.3.6Thailand
7.3.7Rest of APAC
7.4Middle East & Africa Neurostimulation Devices Market Size, Opportunities, Key Trends & Strategic Insights
7.4.1Saudi Arabia
7.4.2United Arab Emirates
7.4.3South Africa
7.4.4Rest of MEA
7.5Latin America Neurostimulation Devices Market Size, Opportunities, Key Trends & Strategic Insights
7.5.1Brazil
7.5.2Mexico
7.5.3Rest of LA
7.6CIS Neurostimulation Devices Market Size, Opportunities, Key Trends & Strategic Insights
7.6.1Russia
7.6.2Rest of CIS
Chapter 8

Competitive Landscape

8.1Competitive Dashboard & Market Share Analysis
8.2Company Profiles (Overview, Financials, Developments, SWOT)
8.2.1Medtronic
8.2.2Boston Scientific
8.2.3Nevro Corp
8.2.4Abbott
8.2.5LivaNova
8.2.6Cyberonics
8.2.7NeuroStar
8.2.8BrainsWay
8.2.9Natus Medical
8.2.10Stimwave
8.2.11Greatbatch Medical
8.2.12Aleva Neurotherapeutics